INMB Operating Cash Flow Growth
Inmune Bio Inc · Operating Cash Flow Growth
INMB Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported53.50%period ending
INMB TTM Cash from Operations YoY % (-249.76% → 53.50%)
Year-over-year change
High-resolution chart · PNG
INMB operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 53.5002% | |
| 41.3862% | |
| 32.2772% | |
| -19.0376% | |
| -39.8272% | |
| -78.5913% | |
| -178.4725% | |
| -80.3909% | |
| -72.1387% | |
| -22.4101% | |
| 47.1921% | |
| 46.6811% | |
| 57.2988% | |
| 53.645% | |
| 20.4112% | |
| -26.7764% | |
| -85.4596% | |
| -148.2703% | |
| -218.7067% | |
| -202.3453% | |
| -222.8369% | |
| -158.3692% | |
| -66.095% | |
| -29.0125% | |
| -33.549% | |
| -61.3882% | |
| -161.5188% | |
| -174.5297% | |
| -133.6661% | |
| -229.3588% | |
| -170.2681% | |
| -211.0295% | |
| -249.7563% |